Position in TGTX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$15,657
New position
Shares Held
285
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#367
of 426 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026VESTOR CAPITAL, LLC holds $261,212,724 across 7 Biotechnology names. TGTX ranks #5 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
700,914 | $260,508,706 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
44,835 | $392,530 | |
| 3 | RPRX |
Royalty Pharma plc
|
4,400 | $246,708 | |
| 4 | TWST |
Twist Bioscience Corp
|
413 | $42,489 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
This page
|
285 | $15,657 | |
| 6 | REPL |
Replimune Group, Inc.
|
557 | $6,165 | |
| 7 | JUNS |
Jupiter Neurosciences, Inc.
|
29 | $469 |
All Filings in TGTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,657 | 285 | Shares | Sole | 2026-07-28 | |
| No filing history on record for this holder in this stock. | ||||||